We are live on ! Find out more
CAM

CG Asset Management Portfolio holdings

AUM $268M
1-Year Est. Return 15.46%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+15.46%
3 Year Est. Return
+62.73%
5 Year Est. Return
10 Year Est. Return
AUM
$249M
AUM Growth
-$698K
Cap. Flow
-$7.47M
Cap. Flow %
-3%
Top 10 Hldgs %
32%
Holding
135
New
16
Increased
34
Reduced
57
Closed
16

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21%
2 Industrials 17.98%
3 Technology 16.75%
4 Healthcare 16.57%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLL
26
DELISTED
L3 Technologies, Inc.
LLL
$3.1M 1.24%
21,145
+3,100
+17% +$416K
TJX icon
27
TJX Companies
TJX
$170B
$3.08M 1.23%
79,710
+5,250
+7% +$200K
DAL icon
28
Delta Air Lines
DAL
$55.9B
$3.06M 1.23%
84,080
-9,785
-10% -$416K
PG icon
29
Procter & Gamble
PG
$343B
$3.02M 1.21%
35,682
-4,593
-11% -$377K
DD icon
30
DuPont de Nemours
DD
$18.6B
$2.87M 1.15%
22,789
+18,625
+447% +$2.45M
MNST icon
31
Monster Beverage
MNST
$91.4B
$2.75M 1.1%
102,594
-5,400
-5% -$130K
GILD icon
32
Gilead Sciences
GILD
$161B
$2.64M 1.06%
31,605
-49,184
-61% -$4.36M
ADBE icon
33
Adobe
ADBE
$89.5B
$2.55M 1.02%
26,575
+3,730
+16% +$358K
ABBV icon
34
AbbVie
ABBV
$458B
$2.53M 1.01%
40,860
-1,720
-4% -$105K
UNH icon
35
UnitedHealth
UNH
$382B
$2.52M 1.01%
17,855
-500
-3% -$66.7K
LCII icon
36
LCI Industries
LCII
$2.51B
$2.51M 1.01%
+29,565
New +$2.13M
LGND icon
37
Ligand Pharmaceuticals
LGND
$6.02B
$2.46M 0.99%
33,102
+22,666
+217% +$1.68M
CRM icon
38
Salesforce
CRM
$134B
$2.41M 0.97%
30,390
-10,245
-25% -$804K
ICE icon
39
Intercontinental Exchange
ICE
$82.4B
$2.31M 0.93%
45,150
-5,550
-11% -$280K
MLM icon
40
Martin Marietta Materials
MLM
$33.6B
$2.21M 0.89%
11,510
+4,960
+76% +$887K
MRK icon
41
Merck
MRK
$324B
$2.21M 0.89%
40,139
MSFT icon
42
Microsoft
MSFT
$2.84T
$2.2M 0.88%
43,040
-7,550
-15% -$392K
SLB icon
43
SLB Ltd
SLB
$77.8B
$2.16M 0.87%
27,359
+15,410
+129% +$1.18M
URI icon
44
United Rentals
URI
$71.1B
$2.15M 0.86%
+32,035
New +$2.09M
SPLK
45
DELISTED
Splunk Inc
SPLK
$2.13M 0.85%
+39,325
New +$2.08M
AOS icon
46
A.O. Smith
AOS
$8.38B
$2.07M 0.83%
46,960
-1,480
-3% -$59.7K
BMY icon
47
Bristol-Myers Squibb
BMY
$127B
$2.06M 0.82%
27,960
-3,479
-11% -$246K
CB icon
48
Chubb
CB
$140B
$1.97M 0.79%
15,089
+400
+3% +$49.3K
KO icon
49
Coca-Cola
KO
$354B
$1.89M 0.76%
41,590
-17,575
-30% -$794K
EVR icon
50
Evercore
EVR
$13.1B
$1.74M 0.7%
39,330
-500
-1% -$24.9K

Similar funds

CG Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, CG Asset Management held 135 positions worth $249M, down 0.28% from $250M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

CG Asset Management's Q2 2016 filing shows 16 new, 34 increased, 57 reduced and 16 closed positions. Its largest new stake was LCI Industries: 29,565 shares worth $2.51M. The largest sale was Gilead Sciences, an estimated $4.36M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

  • CG Asset Management's largest Q2 2016 buy was LCI Industries: 29,565 shares worth $2.51M.
  • CG Asset Management added most to DuPont de Nemours in Q2 2016, an estimated $2.45M increase.
  • CG Asset Management's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $4.36M.
  • CG Asset Management fully exited Macy's in Q2 2016, selling an estimated $2.51M.
  • CG Asset Management's ten largest holdings make up 32% of its $249M portfolio in Q2 2016.
  • CG Asset Management opened 16 new positions and closed 16 in Q2 2016.
  • CG Asset Management's portfolio value fell 0.28% quarter-over-quarter to $249M.

Based on CG Asset Management's 13F filing for Q2 2016, filed 27 Jul 2016.